The Open Group October Virtual Event To Celebrate 25 Years of Open Technology Standards
19.10.2021 11:00:00 EEST | Business Wire | Press release
The Open Group, the vendor-neutral technology standards consortium, is hosting its upcoming “Open Digital Standards” event October 25 – 27, 2021.
The Open Digital Standards event will bring together vendors and end-user organizations from across the globe to discuss how the cross-industry development of open standards is helping businesses become digital-first.
The virtual event will start at 11:30 am Shanghai local time on Tuesday October 26 (8:30 pm PDT October 25), and finish at 1:30 pm local time in Boston on Wednesday October 27. Regional sessions will be hosted in their local languages by all The Open Group offices throughout the globe – Shanghai, Mumbai, London, Sao Paulo, San Francisco, Tokyo, Johannesburg, Boston.
Presentations on Tuesday will focus on the work of The TOGAF® Standard and impact of the UNIX® Standard. Throughout the day, speakers from organizations such as Chevron, NGINX Inc., Capgemini Insights & Data, and National Air Traffic Services, will join TOGAF® Standard Product Manager Sonia Gonzales and Chair of The Open Group ArchiMate® Forum Jean-Baptiste Sarrodie to explore the changing role of Enterprise Architects (EA) and the evolution and impact of ArchiMate®. Presentations will provide practical examples of how these standards are being applied within a range of industries to improve business efficiency.
On Wednesday, attendees will have the opportunity to hear from The Open Group CDO Dave Lounsbury and Micro Focus CTO Dr. Lars Rossen about open standards for the digital enterprise and agile world. Sessions in the afternoon will feature speakers from L3Harris and Lockheed Martin and explore the implications of open technical standards applicable to military and commercial sensor systems including the FACE™ Consortium and SOSA™ Consortium and the recent launch of the Technical Standard for SOSA™ Reference Architecture, Edition 1.0.
Continuing on in the afternoon, Dr. Jack Freund, Head of Cyber Risk Methodology at VisibleRisk, will discuss the value of risk analysis and provide practical guidance on the Open FAIR™ approach, a model and taxonomy for understanding, analyzing, and measuring information risk.
Key speakers at the event include:
- Steve Nunn, President & CEO, The Open Group
- James de Raeve, Vice President, The Open Group
- Junkyo (Jack) Fujieda, Representative and Chairman, The Open Group Japan
- Dr. Pallab Saha, General Manager, The Open Group India
- Stuart Macgregor, Chief Executive, The Open Group South Africa and Real IRM Solutions
- Roberto Severo, Country Manager, The Open Group Brazil
- Andras Szakal, CTO, The Open Group
- Hiroki Habuka, Deputy Director for Global Digital Governance, Ministry of Economy, Trade and Industry, Japan (METI)
- Regine Deleu, General Manager (Digital Architecture), Auckland Transport, Govt of New Zealand
- Patrick Kelly, Product Leader, Chevron
- Kartik Ravel, Senior Director, Digital Transformation Services, Fujitsu
- Dr. Che Haiping, Senior Vice President, Chief Digital Transformation Officer, Huawei Technologies
Additional key topics of discussion include:
- The Role of Standards in a Data Economy – On Tuesday, J. Satyanarayana, Chief Advisor, C4IR India, World Economic Forum Member, Advisory Board, Global Forum on Cyber Expertise (GFCE), Netherlands, will discuss how the use of standards spanning the entire data lifecycle becomes a strategic imperative to accelerate the transition to a data and a digital economy
- Standards in Action: TOGAF, Open FAIR, Open Agile Architecture – On Tuesday, Peter Haviland, Chief Information and Operating Officer, Angle Finance, will recount some hits and misses over the past 15 years contributing to and using The Open Group standards
- Product Integrity and Global Supply Chain Security – On Wednesday, Joanne Woytek, NASA SEWP Program Director, will provide a synopsis of key factors in Supply Chain Risk Management for Acquisition of IT solutions by the US Government with applicability to similar Global market acquisition activities
- A Data-Driven Approach to Environmental Footprint and Sustainability: How Open Footprint impacts GHG Alignment – In various regional sessions, a panel of Open Footprint™ Forum (OFP) experts will discuss why there is a business imperative to address the challenges and current gaps additionally with an overview of what are the global and local challenges followed by what OFP is aiming to address
Agenda and registration details can be found here.
-ENDS-
About The Open Group
The Open Group is a global consortium that enables the achievement of business objectives through technology standards. Our diverse membership of more than 850 organizations includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. Further information on The Open Group can be found at www.opengroup.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005076/en/
Contact information
Meghan Marks
Senior Programme Manager, Hotwire
UKOpengroup@hotwirepr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
